ApoE and Aβ1–42 interactions (original) (raw)

References

• Aleshkov S., Abraham C. R., and Zannis V. I. (1997) Interaction of nascent apoE2, apoE3, and apoE4 isoforms expressed in mammalian cells with amyloid peptide β(1–40): relevance to Alzheimer’s disease. Biochemistry 36, 10571–10580.
  Article PubMed CAS Google Scholar
• Bales K. R., Verina T., Dodel R. C., Du Y., Altstiel L., Bender, M., et al. (1997) Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat. Genet. 17, 263,264.
  Article PubMed CAS Google Scholar
• Barger S. W. and Harmon A. D. (1997) Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 388, 878–881.
  Article PubMed CAS Google Scholar
• Barger S. W. and Mattson M. P. (1997) Isoform-specific modulation by apolipoprotein E of the activities of secreted β-amyloid precursor protein. J. Neurochem. 69, 60–67.
  Article PubMed CAS Google Scholar
• Beffert, U., Aumont N., Dea D., Lussier-Cacan S., Davignon J., and Poirier J. (1999) A polipoprotein E isoformspecific reduction of extracellular amyloid in neuronal cultures. Mol. Brain Res. 68, 181–185.
  Article PubMed CAS Google Scholar
• Chartier-Harlin M. C., Parfitt M., Legrain S., Perez-Tur J., Brousseau T., Evans A., et al. 1994. Apolipoprotein E, ε4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer’s disease: analysis of the 19q13.2 chromosomal region. Hum. Mol. Genet. 3, 569–574.
  Article PubMed CAS Google Scholar
• Choi-Miura, N. H., Ihara Y., Fukuchi K., Takeda M., Nakano Y., Tobe T., and Tomita M. (1992) SP-40,40 is a constituent of Alzheimer’s amyloid. Acta Neuropathol. 83, 260–264.
  Article PubMed CAS Google Scholar
• Chui D. H., Tanahashi H., Ozawa K., Ikeda S., Checler F., Ueda O., et al. (1999) Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation. Nat. Med. 5, 560–564.
  Article PubMed CAS Google Scholar
• Cole G. M. and. Ard M. D. (2000) Influence of lipoproteins on microglial degradation of Alzheimer’s amyloid beta-protein. Microsc. Res. Tech. 50, 316–24.
  Article PubMed CAS Google Scholar
• Cole G. M., Beech W., Frautschy S. A., Sigel J., Glasgow C., and Ard M. D. (1999) Lipoprotein effects on Abeta accumulation and degradation by microglia in vitro. J. Neurosci. Res. 57, 504–520.
  Article PubMed CAS Google Scholar
• Corder E. H., Saunder S. M., Risch N. J., Strittmatter W. J., Schmechel D. E., Gaskell P. C. Jr., et al. (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat. Genet. 7, 180–184.
  Article PubMed CAS Google Scholar
• Corder E. H., Saunder S. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261, 921–923.
  Article PubMed CAS Google Scholar
• Cummings B. J. and Cotman C. W. (1995) Image analysis of beta-amyloid load in Alzheimer’s disease and relation to dementia severity. Lancet 346, 1524–1528.
  Article PubMed CAS Google Scholar
• Dahlgren K. N., Manelli A. M., Stine W. B. Jr., Baker L. K., Krafft G. A., and LaDu M. J. (2002) Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J. Biol. Chem. 277, 32046–32053.
  Article PubMed CAS Google Scholar
• Drouet B., Fifre A., Pincon-Raymond M., Vandekerckhove J., Rosseneu M., Gueant J. L., et al. (2001) ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-beta peptide. J. Neurochem. 76, 117–127.
  Article PubMed CAS Google Scholar
• Evans K. C., Berger E. P., Cho C. G., Weisgraber K. H., and Lansbury P. T. (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 92, 763–767.
  Article PubMed CAS Google Scholar
• Frisoni G. B., Govoni S., Geroldi C., Bianchetti A., Calabresi L., Franceschini G., and Trabucchi M. (1995) Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer’s disease. Ann. Neurol. 37, 596–604.
  Article PubMed CAS Google Scholar
• Ghiso J., Matsubara E., Koudinov A., Choi-Miura N. H., Tomita M., Wisniewski T., and Frangione B. (1993) The cerebrospinal-fluid form of Alzheimer’s amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochem. J. 293, 27–30.
  PubMed CAS Google Scholar
• Guillaume D., Bertrand P., Dea D., Davignon J., and Poirier J. (1996) Apolipoprotein E and low-density lipoprotein binding and internalization in primary cultures of rat astrocytes: isoform-specific alterations. J. Neurochem. 66, 2410–2418.
  Article PubMed CAS Google Scholar
• Haass C. and Steiner H. (2001) Protofibrils, the unifying toxic molecule of neurodegenerative disorders? Nat. Neurosci. 4, 859,860.
  Article PubMed CAS Google Scholar
• Hardy J. and Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297, 353–356.
  Article PubMed CAS Google Scholar
• Hartley D. M., Walsh D. M., Ye C. P., Diehl T., Vasquez S., Vassilev P. M., et al. (1999) Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J. Neurosci. 19, 8876–8884.
  PubMed CAS Google Scholar
• Hartman R. E., Laurer H., Longhi L., Bales K. R., Paul S. M., McIntosh T. K., and Holtzman D. M. (2002) Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer’s disease. J. Neurosci. 22, 10083–10087.
  PubMed CAS Google Scholar
• Holtzman D. M., Bales K. R., Tenkova T., Fagan A. M., Parsadanian M., Sartorius L. J., et al. (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 97, 2892–2897.
  Article PubMed CAS Google Scholar
• Holtzman D. M., Bales K. R., Wu S., Bhat P., Parsadanian M., Fagan A. M., et al. (1999) In vivo expression of apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer’s disease. J. Clin. Invest. 103, R15-R21.
  PubMed CAS Google Scholar
• Houlden H., Crook R., Duff K., Collinge J., Roques P., Rossor M., and Hardy J. (1993) Confirmation that the ApoE4 allele is associated with late onset, familial Alzheimer’s disease. Neurodegeneration 2, 283–286.
  Google Scholar
• Hu J.. LaDu M. J, and Van Eldik L. J. (1998) Apolipoprotein E attenuates beta-amyloid-induced astrocyte activation. J. Neurochem. 71, 1626–1634.
  Article PubMed CAS Google Scholar
• Irizarry M. C., Cheung B. S., Rebeck G. W., Paul S. M., Bales K. R., and Hyman B. T. (2000) Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP (V717F) transgenic mice. Acta Neuropathol. (Berl.) 100, 451–458.
  Article CAS Google Scholar
• Irizarry M. C., Soriano F., McNamara M., Page K. J., Schenk D., Games D., and Hyman B. T. (1997) Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17, 7053–7059.
  PubMed CAS Google Scholar
• Jordán J., Galindo M. F., Miller R. J., Reardon C. A., Getz G. S., and LaDu M. J. (1998) Isoform-specific effect of apolipoprotein E on cell survival and β-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures. J. Neurosci. 18, 195–204.
  PubMed Google Scholar
• Klein W. L., Krafft G. A., and Finch C. E. (2001) Targeting small Abeta oligomers: the solution to an Alzheimer’s disease conundrum? Trends Neurosci. 24, 219–224.
  Article PubMed CAS Google Scholar
• Kuo Y. M., Emmerling M. R., Vigo-Pelfrey C., Kasunic T. C., Kirkpatrick J. B., Murdoch G. H., et al. (1996) Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077–81.
  Article PubMed CAS Google Scholar
• LaDu M. J., Falduto M. T., Manelli A. M., Reardon C. A., Getz G. S., and Frail D. E. (1994) Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269, 23404–23406.
  Google Scholar
• LaDu M. J., Lukens J. R., Reardon C. A., and Getz G. S. (1997) Association of human, rat, and rabbit apolipoprotein E with beta-amyloid. J. Neurosci. Res. 49, 9–18.
  Article PubMed CAS Google Scholar
• LaDu M. J., Pederson T. M., Frail D. E., Reardon C. A., Getz G. S., and Falduto M. T. (1995) Purification of apolipoprotein E attenuates isoform-specific binding to β-amyloid. J. Biol. Chem. 270, 9030–9042.
  Google Scholar
• LaDu M. J., Shah J. A., Reardon C. A., Getz G. S., Bu G., Hu J., et al. (2000) Apolipoprotein E receptors mediate the effects of beta-amyloid on astrocyte cultures. J. Biol. Chem. 275, 33974–33980.
  Article PubMed CAS Google Scholar
• LaDu M. J., Shah J. A., Reardon C. A., Getz G. S., Bu G., Hu J., et al. (2001) Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses. Neurochem. Int. 39, 427–434.
  Article PubMed CAS Google Scholar
• Lambert M. P., Barlow A. K., Chromy B. A., Edwards C., Freed R., Liosatos M., et al. (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448–6453.
  Article PubMed CAS Google Scholar
• Lansbury P. T. Jr. (1999) Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl. Acad. Sci. USA 96, 3342–3344.
  Article PubMed CAS Google Scholar
• Laskowitz D. T., Goel S., Bennett E. R., and Matthew W. D. (1997) Apolipoprotein E suppresses glial cell secretion of TNF alpha. J. Neuroimmunol. 76, 70–74.
  Article PubMed CAS Google Scholar
• Laskowitz, D. T., Matthew W. D., Bennett E. R., Schmechel D., Herbstreith M. H., Goel S., and McMillian M. K. (1998) Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production. Neuroreport 9, 615–618.
  Article PubMed CAS Google Scholar
• Lue L. F., Kuo Y. M., Roher A. E., Brachova L., Shen Y., Sue L., et al. (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer’s disease. Am. J. Pathol. 155, 853–862.
  PubMed CAS Google Scholar
• Lynch, J. R., Morgan D., Mance J., Matthew W. D., and Laskowitz D. T. (2001) Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response. J. Neuroimmunol. 114, 107–113.
  Article PubMed CAS Google Scholar
• Ma J., Brewer H. B. Jr., and Potter H. (1996) Alzheimer A beta neurotoxicity: promotion by antichymotrypsin, ApoE4; inhibition by A beta-related peptides. Neurobiol. Aging 17, 773–780.
  Article PubMed CAS Google Scholar
• Ma J., Yee A., Brewer H. B., Das S., and Potter H. (1994) Amyloid-associated proteins alpha-1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372, 92–94.
  Article PubMed CAS Google Scholar
• Mak Y. T., Chiu H., Woo J., Kay R., Chan Y. S., Hui E., et al. (1996) Apolipoprotein E genotype and Alzheimer’s disease in Hong Kong elderly Chinese. Neurology 46, 146–149.
  PubMed CAS Google Scholar
• Matsubara E., Frangione B., and Ghiso J. (1995) Characterization of apolipoprotein J-Alzheimer’s Aβ interaction. J. Biol. Chem. 270, 7563–7567.
  Article PubMed CAS Google Scholar
• McLean C. A., Cherny R. A., Fraser F. W., Fuller S. J., Smith M. J., Beyreuther K., et al. (1999) Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer’s disease. Ann. Neurol. 46, 860–866.
  Article PubMed CAS Google Scholar
• Miyata M. and Smith J. D. (1996) Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat. Genet. 14, 55–61.
  Article PubMed CAS Google Scholar
• Mouchel Y., Lefrancois T., Fages C., and Tardy M. (1995) Apolipoprotein E expression in astrocytes: developmental pattern and regulation. Neuroreport 7, 205–208.
  PubMed CAS Google Scholar
• Namba Y., Tomonaga M., Kawasaki H., Otomo E., and Ikeda K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease kuru plaque amyloid in Creutzfeldt-Jacob disease. Brain Res. 541, 163–166.
  Article PubMed CAS Google Scholar
• Naslund J., Haroutunian V., Mohs R., Davis K. L., Davies P., Greengard P., and Buxbaum J. D. (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283, 1571–1577.
  Article PubMed CAS Google Scholar
• Oda, T., Wals P., Osterburg H. H., Johnson S. A., Pasinetti G. M., Morgan T. E., et al. (1995) Clusterin (apoJ) alters the aggregation of amyloid beta-peptide (A beta 1-42) and forms slowly sedimenting A beta complexes that cause oxidative stress. Exp. Neurol. 136, 22–31.
  Article PubMed CAS Google Scholar
• Pericak-Vance M. A., Johnson C. C., Rimmler J. B., Saunders A. M., Robinson L. C., D’Hondt E. G., et al. (1996) Alzheimer’s disease and apolipoprotein E-4 allele in an Amish population. Ann. Neurol. 39, 700–704.
  Article PubMed CAS Google Scholar
• Rebeck G. W., Reiter J. S, Strickland D. K., and Hyman B. T. (1993) Apolipoprotein E in sporadic Alzheimer’s disease: allelic variation and receptor interactions. Neuron 11, 575–580.
  Article PubMed CAS Google Scholar
• Roher A. E., Baudry J., Chaney M. O., Kuo Y. M., Stine W. B., and Emmerling M. R. (2000) Oligomerization and fibril assembly of the amyloid-beta protein. Biochim. Biophys. Acta 1502, 31–43.
  PubMed CAS Google Scholar
• Roher A. E., Chaney M. O., Kuo Y. M., Webster S. D., Stine W. B., Haverkamp L. J., et al. (1996) Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer’s disease. J. Biol. Chem. 271, 20631–20635.
  Article PubMed CAS Google Scholar
• Royston M. C., Mann D., Pickering-Brown S., Owen F., Perry R., Raghavan R., et al. 1994 Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down’s syndrome from dementia. Neuroreport 5, 2583–2585.
  Article PubMed CAS Google Scholar
• Sanan D. A., Weisgraber K. H., Russel S. J., Mahley R. W., Huang D., Saunders A., et al. (1994) Apolipoprotein E associates with β amyloid peptide of Alzheimer’s disease to form novel monofibrils. J. Clin. Invest. 94, 860–869.
  Article PubMed CAS Google Scholar
• Saunders A. M., Schmader K., Breitner J. C. S., Benson M. D., Brown W. T., Goldfarb L., et al. (1993) Apolipoprotein E ε4 allele distributions in late-onset Alzheimer’s disease and in other amyloid-forming diseases. Lancet 342, 710–711.
  Article PubMed CAS Google Scholar
• Selkoe D. J. (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol. Rev. 81, 741–766.
  PubMed CAS Google Scholar
• Small D. H. (1998) The amyloid cascade hypothesis debate: emerging consensus on the role of A beta and amyloid in Alzheimer’s disease, in The Sixth International Conference on Alzheimer’s disease, Vol. 5, The Parthenon Publishing Group, Amsterdam, The Netherlands, pp. 301–304.
  Google Scholar
• Stine W. B. Jr., Dahlgren K. N., Krafft G. K., and LaDu M. J. (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J. Biol Chem. 278, 11612–11622.
  Article PubMed CAS Google Scholar
• Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., and Roses A. D. (1993) Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA 90, 1977–1981.
  Article PubMed CAS Google Scholar
• Sullivan P. M., Mezdour H., Aratani Y., Knouff C., Najib J., Reddick R. L., et al. (1997) Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. 272, 17972–17980.
  Article PubMed CAS Google Scholar
• Terry R. D. 2001 An honorable compromise regarding amyloid in Alzheimer disease. Ann Neurol. 49, 684.
  Article PubMed CAS Google Scholar
• Tokuda T., Calero M., Matsubara E., Vidal R., Kumar A., Permanne B., et al. (2000) Lipidation of apolipoprotein E influences its isoform-specific interaction with Alzheimer’s amyloid β-peptide. Biochem. J. 348, 359–365.
  Article PubMed CAS Google Scholar
• Tsai M. S., Tangalos E. G., Petersen R. C., Smith G. E., Schaid D. J., Kokmen E., et al. (1994) Apolipoprotein E: risk factor for Alzheimer disease. Am. J. Hum. Genet. 54, 643–649.
  PubMed CAS Google Scholar
• Urmoneit B., Prikulis I., Wihl G., D’Urso D., Frank R., Heeren J., et al. (1997) Cerebrovascular smooth muscle cells internalize Alzheimer amyloid beta protein via a lipoprotein pathway: implications for cerebral amyloid angiopathy. Lab. Invest. 77, 157–166.
  PubMed CAS Google Scholar
• van Duijn C. M., de Knijff P., Cruts M., Wehnert A., Havekes L. M., Hofman A., and Van Broeckhoven C. (1994) Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer’s disease. Nat. Genet. 7, 74–78.
  Article PubMed Google Scholar
• Walsh D. M., Hartley D. M., Kusumoto Y., Fezoui Y., Condron M. M., Lomakin A., et al. (1999) Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274, 25945–25952.
  Article PubMed CAS Google Scholar
• Walsh D. M., Klyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolfe M. S., et al. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535–539.
  Article PubMed CAS Google Scholar
• Whitson J. S., Mims M. P., Strittmatter W. J., Yamaki T., Morrisett J. D., and Appel S. H. (1994) Attenuation of the neurotoxic effect of A beta amyloid peptide by apolipoprotein E. Biochem. Biophys. Res. Commun. 199, 163–170.
  Article PubMed CAS Google Scholar
• Winkler K., Scharnagl H., Tisljar U., Hoschutzky H., Friedrich I., Hoffmann M. M., et al. (1999) Competition of Abeta amyloid peptide and apolipoprotein E for receptor-mediated endocytosis. J. Lipid Res. 40, 447–455.
  PubMed CAS Google Scholar
• Wisniewski T. and Frangione B. (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235–238.
  Article PubMed CAS Google Scholar
• Wisniewski T., Castano E. M., Golabek A., Vogel T., and Frangione B. (1994) Acceleration of Alzheimer’s fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145, 1030–1035.
  PubMed CAS Google Scholar
• Wisniewski T., Golabek A., Matsubara E., Ghiso J., and Frangione B. (1993) Apolipoprotein E: binding to soluble Alzheimer’s beta-amyloid. Biochem. Biophys. Res. Commun. 192, 359–365.
  Article PubMed CAS Google Scholar
• Yang D. S., Small D. H., Seydel U., Smith J. D., Hallmayer J., Gandy S. E., and Martins R. N. (1999) Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner. Neuroscience 90, 1217–1226.
  Article PubMed CAS Google Scholar
• Yang D.- S., Smith J. D., Zhou Z., Gandy S., and Martins R. N. (1997) Characterization of the binding of amyloid-β peptide to cell culture-derived native apolipoprotein E2, E3, and E4 isoforms and to isoforms from human plasma. J. Neurochem. 68, 721–725.
  Article PubMed CAS Google Scholar
• Yu C. E., Payami H., Olson J. M., Boehnke M., Wijsman E. M., Orr H. T., et al. (1994) The apolipoprotein E/CI/CII gene cluster and late-onset Alzheimer disease. Am. J. Hum. Genet. 54, 631–642.
  PubMed CAS Google Scholar
• Zhou Z., Smith J. D., Greengard P., and Gandy S. (1996) Alzheimer amyloid-beta peptide forms denaturant-resistant complex with type epsilon 3 but not type epsilon 4 isoform of native apolipoprotein E. Mol. Med. 2, 175–180.
  Article PubMed CAS Google Scholar

Download references